Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

1,123 companies

Ticker	Company	Revenue	Net income ▾	Net margin	Return on equity	Revenue growth	Diluted EPS
SVRA	Savara Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$118.84M	n/a	-58.5%	n/a	-$0.53
VYGR	Voyager Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.37M	-$119.72M	-296.5%	-61.1%	-49.5%	-$2.04
TYRA	Tyra Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$119.95M	n/a	-46.3%	n/a	-$2.01
TLRY	Tilray Brands, Inc. Manufacturing · Year ended 2026-05-31 · USD	$915.45M	-$121.40M	-13.3%	-7.5%	11.5%	-$1.09
TNXP	Tonix Pharmaceuticals Holding Corp. Manufacturing · Year ended 2025-12-31 · USD	$13.11M	-$124.02M	-946.2%	-50.6%	29.8%	-$14.57
ERAS	Erasca, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$124.55M	n/a	-38.3%	n/a	-$0.44
IE	Ivanhoe Electric Inc. Mining · Year ended 2025-12-31 · USD	$3.24M	-$125.05M	n/m	-30.1%	11.8%	$0.79
JBIO	Jade Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$127.41M	n/a	-38.3%	n/a	-$3.19
ORIC	Oric Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$129.47M	n/a	-33.7%	n/a	-$1.47
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05
MAZE	Maze Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$131.12M	n/a	-36.9%	n/a	-$3.05
KMTS	Kestra Medical Technologies, Ltd. Manufacturing · Year ended 2026-04-30 · USD	$95.13M	-$131.61M	-138.4%	-50.7%	59.0%	-$2.43
PONY	Pony AI Inc. Services · Year ended 2025-12-31 · USD	$90.00M	-$133.97M	-148.9%	-8.1%	20.0%	-$0.35
BBOT	BridgeBio Oncology Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$134.04M	n/a	-32.6%	n/a	-$4.30
ZNTL	Zentalis Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$137.06M	n/a	-63.4%	-100.0%	-$1.91
UEC	Uranium Energy Corp Mining · Year ended 2026-07-31 · USD	$37.25M	-$137.31M	-368.6%	-10.0%	-44.3%	-$0.28
IPST	IP Strategy Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.12M	-$137.72M	n/m	-140.2%	20.4%	-$16.03
BCAX	Bicara Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$137.95M	n/a	-34.4%	n/a	-$2.52
FDMT	4D Molecular Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.21M	-$140.11M	-164.4%	-27.7%	n/m	-$2.42
GPCR	Structure Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$141.20M	n/a	-9.3%	n/a	-$0.80
UPB	Upstream Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.85M	-$143.44M	n/m	-42.2%	20.4%	-$2.66
TRDA	Entrada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.42M	-$143.75M	-565.5%	-47.0%	-87.9%	-$3.47
AMLX	Amylyx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$144.74M	n/a	-47.4%	-100.0%	-$1.53
ABCL	AbCellera Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$75.13M	-$146.41M	-194.9%	-15.1%	160.6%	-$0.49
DBVT	DBV Technologies S.A. Manufacturing · Year ended 2025-12-31 · USD	$5.64M	-$146.95M	n/m	-87.1%	35.8%	-$1.05

Rows per page: 2550 100